Tri-sprintec and Hydroxyzine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tri-sprintec (ethinyl estradiol; norgestimate) and Hydroxyzine (hydroxyzine hydrochloride). Common drug interactions include dry skin among females.

The phase IV clinical study analyzes what interactions people have when they take Tri-sprintec and Hydroxyzine. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Tri-sprintec?

Tri-sprintec has active ingredients of ethinyl estradiol; norgestimate. It is often used in birth control. eHealthMe is studying from 1,428 Tri-sprintec users. Check the latest studies of Tri-sprintec.

What is Hydroxyzine?

Hydroxyzine has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 54,069 Hydroxyzine users. Check the latest studies of Hydroxyzine.



On Jul, 10, 2026

30 people who take Tri-sprintec and Hydroxyzine together, and have interactions are studied.

Tri-sprintec and Hydroxyzine drug interactions.

What are the common drug interactions of Tri-Sprintec and Hydroxyzine, by gender? *:

female:

  1. Dry skin
  2. Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
  3. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
  4. Renal injury (kidney injury)
  5. Renal tubular necrosis (death of kidney tubules)
  6. Visual impairment
  7. Abdominal discomfort
  8. Cystitis interstitial (unknown cause characterized by bladder pain)
  9. Depression
  10. Drug hypersensitivity

male:

n/a

What are the common drug interactions of Tri-Sprintec and Hydroxyzine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Injection site reaction
  2. Rash
  3. Septic shock (shock due to blood infection)

20-29:

  1. Dry skin
  2. Eye pain
  3. Eye swelling
  4. Ocular hyperaemia (an abnormally large amount of blood in eye)
  5. Conjunctivitis (pink eye)
  6. Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
  7. Eye pruritus (eye itching)
  8. Intraocular pressure increased
  9. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
  10. Visual impairment

30-39:

  1. Abdominal discomfort
  2. Cystitis interstitial (unknown cause characterized by bladder pain)
  3. Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
  4. Fatigue (feeling of tiredness)
  5. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
  6. Haematuria (presence of blood in urine)
  7. Headache (pain in head)
  8. Pain
  9. Pyrexia (fever)
  10. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

40-49:

  1. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  2. Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
  3. Panniculitis (inflammation of the subcutaneous fat)
  4. Vision blurred
  5. Chronic kidney disease
  6. Renal injury (kidney injury)
  7. Renal tubular necrosis (death of kidney tubules)

50-59:

  1. Chronic kidney disease
  2. Drug ineffective
  3. Heart rate decreased
  4. Heart rate increased
  5. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  6. Renal failure (kidney dysfunction)
  7. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

60+:

n/a

What are the existing conditions these people have? *

  1. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 12 people, 40.00%
  2. Itching: 5 people, 16.67%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 16.67%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 13.33%
  5. Multiple Allergies (allergy to multiple agents): 4 people, 13.33%
  6. Asthma: 4 people, 13.33%
  7. Depression: 3 people, 10.00%
  8. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 6.67%
  9. Swelling: 2 people, 6.67%
  10. Psoriasis (immune-mediated disease that affects the skin): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Tri-sprintec and Hydroxyzine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tri-sprintec and Hydroxyzine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tri-sprintec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hydroxyzine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tri-sprintec and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydroxyzine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; norgestimate and hydroxyzine hydrochloride (the active ingredients of Tri-sprintec and Hydroxyzine, respectively), and Tri-sprintec and Hydroxyzine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: